The Endpoints 20 under 40, biotech’s new normal, Stéphane Bancel’s one regret, and more

Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.

What a week! We were proud to present a...

Click to view original post